ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2021 > CANCELLED: ESO-ESGO-ENYGO Course on Pathology of Gynaecological Tumors
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

CANCELLED: ESO-ESGO-ENYGO Course on Pathology of Gynaecological Tumors

9 ESCO credits

17.11.2021  -  19.11.2021

Ljubjana, Slovenia


Gynaecological cancers, Pathology



The ESO-ESGO-ENYGO Course on pathology of gynaecological tumours has been designed for pathologists, gynecological oncologists and medical oncologists, with the aim to provide an update on the State of-the art diagnostics as well as an overview of the latest advances in the field of gynaecological oncology.

Moreover, spotlight lectures will cover specific issues related to particular situations such as diagnostic dilemmas in challenging cases.

Practical training will be offered in the frame of „tumour board“ sessions in a mode of case presentations, prepared and presented by participants and discussed with the faculty.


  • Update on the latest advances in diagnostic procedures in gynaecological cancers
  • Improve practical skills in solving diagnostic dilemas/problems and setting the best diagnosis and treatment for gynaecological cancer patients
  • Update on the latest advances and on the state-of- the-art treatment options
  • Debate on controversies and challenges in gynaecological cancer diagnostics and treatment
  • Learn about the management of specific situation


  • Gyneacological cancer pathology
  • Update on standard and new diagnostic and treatment options for gynaecological cancer
  • Pathological diagnosis and treatment of gynaecological cancer – closer than ever
The Course is an ESO-ESGO-ENYGO joint event   





General Information

Alice Ciocchini
European School of Oncology
Via Turati 29, 20121, Milan (IT)
Email: aciocchini@eso.net

Dolores Knupfer
European School of Oncology
Piazza Indipendenza 1, Bellinzona (CH)
Email: dknupfer@eso.net

Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.


Being selected to take part in this ESO actvity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
It also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in this course earns participants 9 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

In the event of registrations to events held in partnership with other entities (clearly specified in the title of the event or by sending a request to ESO), please be aware that the partner should be considered joint data controller and that the consents provided to ESO will be transferred to the partner as well. Any subsequent consent modifications will need to be communicated to the partner directly.


Admittance to the course is by competitive application.

- The fee for successful applicants is 120€
- Selected participants coming from low-middle-income Countries (as defined by the World Bank) will have to cover a discounted fee of 80€

Non-local participants will be offered accommodation for the period 17-19 November 2021. Travel will be covered by participants.

Applications made as a team from the same institute - i.e. at least two members: pathologist  and surgeon, pathologist and medical oncologist, pathologist and radiotherapist etc. - to promote multisdiciplinarity are welcome.

Full participation is compulsory throughout the course for all participants.

The course will be entirely in English and fluency in English is necessary for admission.


  • Letter describing motivation for attending the event– please mention here if you are participating with a team member and add their name
  • Short CV – complete template provided
  • Supporting letter from Head of Department/Mentor
  • Abstract (complete template provided) with proposed presentation of a pathological case relating to one of the main themes of the course:
    • Cervix
    • Endometrial
    • Ovary

The abstract should be presented in the form of a brief case discussion and describe:

  • Diagnostic considerations
  • Treatment
  • Outcome (follow-up)
  • Up to three questions that the author proposes for discussion by the faculty and participants



  • Download HERE your CV template
  • Download HERE your Abstract template

ESCO Members

Free registration will be awarded to 10 ESCO members (Students, Fellows & Graduates) based on their ESCO profile.
ESCO enrolment must be carried out before the application deadline at www.esco.org in order to be consider for this benefit and interested ESCO applicants should complete the application procedure as normal



17 November

19:30Welcome dinner

18 November

8:30Welcome address and general introduction
9:00Cervical cancer - part 1
 9:00New aspects on adenocarcinoma of the cervix
Ermina Iljazovic, BA
 9:30Diagnosis of microinvasive cervical cancer
  Challenge for colposcopist
Spela Smrkolj, SI
  Challenge for pathologist
Snježana Grazio, SI
 10:10Rare histological types:
  Challenge for pathologist
Ermina Iljazovic, BA
  Challenge for clinician
Jure Knez, SI
10:50Coffee break
11:20Cervical cancer - part 2
 11:20Fertility preservation in early cervical cancer: to whom it should be offered
Giovanni Damiano Aletti, IT
 11:50Clinical and pathological aspects of lymphnode staging in cervical cancer
  Challenge the pathologist
Sigurd Lax, AT
  Challenge the clinician
Giovanni Damiano Aletti, IT
12:30Tumour board: 4 Selected cases presented by participants and discussed with the faculty
14:30Endometrial cancer
 14:30Uterine sarcoma
  Challenge the pathologist
Sigurd Lax, AT
  Challenge the clinician
Ignacio Zapardiel, ES
 15:10Different methods of biopsies: limitations for diagnosis?
Gianfranco Zannoni, IT
 15:40Conservative management of atypical hyperplasia and early endometrial cancer
  Challenge for clinician
Ignacio Zapardiel, ES
  Challenge for pathologist
Sigurd Lax, AT
 16:20Molecular classification of endometrial cancer – does pathology influence the treatment?
  View of pathologist
Gianfranco Zannoni, IT
  View of clinician
Cristiana Sessa, CH
17:00Coffee break
17:30Tumour board: 4 Selected cases presented by participants and discussed with the faculty

19 November

8:30Ovarian cancer - part 1
 8:30Borderline tumors: a never-ending challenge
  View of pathologist
Sigurd Lax, AT
  View of clinician
Maja Pakiz, SI
 9:10Evaluation of response after neoadjuvant treatment (CRS)
Gianfranco Zannoni, IT
 9:40Management of non-chemo-sensitive tumors: an unresolved issue
  View of clinician
Cristiana Sessa, CH
  View of pathologist
Snježana Grazio, SI
10:20Coffee break
10:30Ovarian cancer - part 2
 10:30Clinical implementation of ovarian cancer molecular profile: is it the way to the personalized treatment?
Cristiana Sessa, CH
11:00Tumour board: 4 Selected cases presented by participants and discussed with the faculty
12:00Learning self-assessment test
12:30Best clinical case award, farewell address and wrap up


Giovanni Damiano Aletti, IEO - European Institute of Oncology, Gyneacological Cancer Dpt., Milano, IT
Snježana Grazio, University Medical Center Ljubljana, Gyneacological Pathology Dpt., Ljubljana, SI
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, BA
Jure Knez, UKC Maribor, Gyneacological Cancer Dpt., Maribor, SI
Nina Kovacevic, Institute of Oncology Ljubljana, Oncology Dpt., Ljubljana, SI
Sigurd Lax, General Hospital Graz West, Dept. of Pathology, Graz, AT
Maja Pakiz, University Medical Centre Maribor, Oncology Dpt., Maribor, SI
Andrei Pletnev, N.N. Alexandrov National Cancer Center of Belarus, Gynecologic Oncology Dpt., Minsk, BY
Ilker Selcuk, Zekai Tahir Burak Women Diseases, Education and Research Hospital, Cankaya, TR
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Spela Smrkolj, University Medical Centre Ljubljana, Oncology Dpt., Ljubljana, SI
Gianfranco Zannoni, Policlinico Gemelli, Anatomo-pathology Dpt., Roma, IT
Ignacio Zapardiel, La Paz University Hospital, Gynecologic Oncology Unit, Madrid, ES